Deutsche Bank AG acquired a new position in shares of AMN Healthcare Services Inc (NYSE:AMN - Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 41,438 shares of the company's stock, valued at approximately $1,341,000. Deutsche Bank AG owned about 0.11% of AMN Healthcare Services at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Royal Bank of Canada lifted its position in shares of AMN Healthcare Services by 1.5% during the first quarter. Royal Bank of Canada now owns 194,366 shares of the company's stock valued at $4,753,000 after buying an additional 2,784 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of AMN Healthcare Services by 54.2% in the 1st quarter. AQR Capital Management LLC now owns 98,026 shares of the company's stock valued at $2,398,000 after buying an additional 34,465 shares in the last quarter. Jacobs Levy Equity Management Inc. purchased a new position in shares of AMN Healthcare Services in the 1st quarter worth approximately $283,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of AMN Healthcare Services by 2.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 42,938 shares of the company's stock worth $1,050,000 after buying an additional 1,153 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of AMN Healthcare Services by 13.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 429,908 shares of the company's stock worth $10,516,000 after acquiring an additional 51,737 shares in the last quarter. Institutional investors own 99.23% of the company's stock.
Insiders Place Their Bets
In other news, Director Mark G. Foletta sold 3,681 shares of the business's stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $31.07, for a total transaction of $114,368.67. Following the transaction, the director directly owned 17,917 shares in the company, valued at $556,681.19. The trade was a 17.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.07% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on AMN shares. Truist Financial boosted their target price on AMN Healthcare Services from $26.00 to $40.00 and gave the stock a "buy" rating in a research note on Wednesday, July 22nd. Citizens Jmp increased their price target on AMN Healthcare Services from $36.00 to $40.00 and gave the company a "market outperform" rating in a research note on Friday, August 14th. Weiss Ratings raised AMN Healthcare Services from a "sell (d-)" rating to a "sell (d+)" rating in a report on Tuesday, August 11th. Wall Street Zen lowered AMN Healthcare Services from a "buy" rating to a "hold" rating in a research note on Tuesday, August 25th. Finally, UBS Group upped their price objective on shares of AMN Healthcare Services from $32.00 to $35.00 and gave the company a "neutral" rating in a report on Friday, August 7th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, AMN Healthcare Services has an average rating of "Hold" and a consensus price target of $31.43.
Get Our Latest Report on AMN Healthcare Services
AMN Healthcare Services News Summary
Here are the key news stories impacting AMN Healthcare Services this week:
- Positive Sentiment: Zacks raised its FY2026 EPS estimate to $3.22 from $2.59, above the broader consensus estimate of $3.10. It also increased its Q3 2026 forecast to $0.20 from $0.14 and Q4 2026 to $0.15 from $0.14, indicating better expected profitability in the near term. AMN Healthcare Services analyst estimates
- Positive Sentiment: The firm lifted its Q3 2027 EPS estimate to $0.31 from $0.26 and its Q2 2028 estimate to $0.37 from $0.33, providing some longer-term support for the earnings outlook. AMN Healthcare Services earnings estimates
- Neutral Sentiment: Zacks’ “Hold” rating was unchanged. Its current full-year consensus reference remains $3.10 EPS, while the company’s latest reported quarter showed stronger-than-expected results, with $0.77 EPS and $673.2 million in revenue versus estimates of $0.19 and $628.4 million, respectively.
- Negative Sentiment: The estimate increases were outweighed by several reductions in later-period forecasts. Zacks cut Q2 2027 EPS to $0.26 from $0.31, Q4 2027 to $0.29 from $0.45, FY2027 to $1.05 from $1.20, Q1 2028 to $0.30 from $0.46, and FY2028 to $1.40 from $1.48. These revisions point to weaker expected earnings growth beyond 2026 and likely explain the pressure on AMN shares.
AMN Healthcare Services Trading Down 1.5%
NYSE AMN opened at $34.56 on Friday. AMN Healthcare Services Inc has a 1 year low of $14.97 and a 1 year high of $37.22. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.13 and a quick ratio of 1.13. The company has a market capitalization of $1.34 billion, a PE ratio of 12.90, a P/E/G ratio of 1.27 and a beta of 0.40. The company has a fifty day moving average of $33.61 and a 200 day moving average of $26.57.
AMN Healthcare Services (NYSE:AMN - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.58. The firm had revenue of $673.24 million during the quarter, compared to analyst estimates of $628.39 million. AMN Healthcare Services had a net margin of 3.06% and a return on equity of 19.92%. The business's quarterly revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.30 EPS. Research analysts forecast that AMN Healthcare Services Inc will post 3.31 earnings per share for the current year.
About AMN Healthcare Services
(
Free Report)
AMN Healthcare Services, Inc NYSE: AMN is a leading provider of healthcare workforce solutions in the United States. The company specializes in staffing and recruitment services for a broad range of clinical and allied health professionals, including travel nurses, permanent placement of nursing staff, locum tenens physicians, and allied health personnel. In addition to direct staffing, AMN Healthcare offers comprehensive workforce management solutions such as vendor management systems (VMS), recruitment process outsourcing (RPO), and compliance and credentialing services through its technology platforms.
Founded in 1985 as American Mobile Nurses, the company rebranded to AMN Healthcare in 2010 to reflect its expanding portfolio of services.
Featured Stories
Want to see what other hedge funds are holding AMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMN Healthcare Services Inc (NYSE:AMN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMN Healthcare Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMN Healthcare Services wasn't on the list.
While AMN Healthcare Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.